A Herpes Simplex Virus 2 (HSV-2) Glycoprotein D-expressing Nonreplicating Dominant-Negative HSV-2 Virus Vaccine Is Superior to a gD2 Subunit Vaccine against HSV-2 Genital Infection in Guinea Pigs

Open Access

Peer-reviewed

Research Article

Pengwei Zhang,

Affiliation Department of Surgery, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, United States of America
⨯
Lining Xie,

Affiliation Department of Surgery, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, United States of America
⨯
John W. Balliet,

Affiliation Vaccine Research, Merck Research Laboratories, Merck & Co., Inc., West Point, Pennsylvania, United States of America
⨯
Danilo R. Casimiro,

Affiliation Vaccine Research, Merck Research Laboratories, Merck & Co., Inc., West Point, Pennsylvania, United States of America
⨯
Feng Yao

* E-mail: fyao@rics.bwh.harvard.edu

Affiliation Department of Surgery, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, United States of America
⨯

Reader Comments (0)

Herpes simplex virus-2
Is the Subject Area "Herpes simplex virus-2" applicable to this article?

Thanks for your feedback.
Guinea pigs
Is the Subject Area "Guinea pigs" applicable to this article?

Thanks for your feedback.
Viral vaccines
Is the Subject Area "Viral vaccines" applicable to this article?

Thanks for your feedback.
Antibody response
Is the Subject Area "Antibody response" applicable to this article?

Thanks for your feedback.
Viral replication
Is the Subject Area "Viral replication" applicable to this article?

Thanks for your feedback.
Antibodies
Is the Subject Area "Antibodies" applicable to this article?

Thanks for your feedback.
Recombinant vaccines
Is the Subject Area "Recombinant vaccines" applicable to this article?

Thanks for your feedback.
Herpes simplex virus-1
Is the Subject Area "Herpes simplex virus-1" applicable to this article?

Thanks for your feedback.